VistaGen Therapeutics, Inc. Soared

Tue 10 Dec 19 at 05:30 PM
VistaGen Therapeutics, Inc. Soared

VistaGen Therapeutics, Inc. (VTGN:NASDAQ) rocketted at $0.62, representing a gain of 44.6%. The stock appeared on our News Catalysts scanner on Tue 10 Dec 19 at 09:30 AM in the 'BIOTECH' category. From Mon 18 Nov 19, the stock recorded 42.86% Up Days and 46.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)

VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.

Share